Purpura, Schoenlein-Henoch
5
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
10 treatments under study, led by Antithymocyte Globulin
Research Leaders
8 sponsors active, led by Liaoning University of Traditional Chinese Medicine
Related Conditions
Often studied with 13 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 in Children With Henoch-schönlein Purpura
Identification of Biomarkers Predictive of Worse Prognosis in Henoch Schonlein Purpura
HSP-glomerulonephritis Trial: MP vs CyA
Research on the Blood- Cooling - Toxin - Removing - Stasis - Dispersing Protocol Evaluation of Hench-schonlein Purpura
Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
Research Network
Common Treatments
- Antithymocyte Globulin1
- Cyclophosphamide1
- Filgrastim1
- Cyclosporine1
- Methylprednisolone1
Active Sponsors
- Liaoning University of Traditional Chinese Medicine1
- Shenyang Hospital of Integrated Traditional and westen Medicine1
- Oulu University Hospital1
- Assistance Publique - Hôpitaux de Paris1
- Fairview University Medical Center1
Top Investigators
Dalian Children's Hospital
The First Hospital of Jilin University
Dongzhimen Hospital, Beijing
Dept. of Pediatrics, Oulu University Hospital
Shenyang Hospital of Integrated Traditional and westen Medicine
Related Conditions
- Juvenile Rheumatoid Arthritis1
- Wegeners Granulomatosis1
- Polyarteritis Nodosa1
- Pure Red Cell Aplasia1
- Autoimmune Thrombocytopenic Purpura1